Low frequency of lymph-node metastasis in BRCA1-associated breast cancer

Lancet

Volumn 351, Issue 9116, 1998, Pages 1633-1634

  Eisinger, François ^d   Noguès, Catherine ^d   Birnbaum, Daniel ^d   Jacquemier, Jocelyne ^d   Sobol, Hagay ^a,b,c  

^a INSERM   (France)

^b Center René Huguenin   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0032580696     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77689-3     Document Type: Article

References (5)

1. 1 Eisinger F, Stoppa-Lyonnet D. Longy M, et al. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 1996; 56: 471-74.
2. 2 Verhoog L, Brekelmans C, Seynaeve C, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351: 316-21.
3. 3 Eisinger F, Jacquemier J, Guinebretiere J-M, Birnbaum D, Sobol H. p53 involvement in BRCA1-associated breast cancer. Lancet 1997; 350: 1101.
4. 4 Carter C, Allen C, Henson D. Relation of tumor size, lymph node status and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-87.
5. 5 Eisinger F, Julian-Reynier C, Chabal F, Luquet C, Moatti JP, Sobol H. Acceptable strategies for dealing with hereditary breast/ovarian cancer risk. J Natl Cancer Inst 1997; 89: 731.